{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:31:58Z","timestamp":1792852318346,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijbiomac.2024.134406","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T03:08:51Z","timestamp":1722654531000},"page":"134406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P3","title":["Fabrication of folic acid-conjugated pyrimidine-2(5H)-thione-encapsulated curdlan gum-PEGamine nanoparticles for folate receptor targeting breast cancer cells"],"prefix":"10.1016","volume":"277","author":[{"given":"Selvaraj","family":"Kunjiappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theivendren","family":"Panneerselvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuraman","family":"Pavadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanavil","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sureshbabu Ram Kumar","family":"Pandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponnusamy","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugesan","family":"Sankaranarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmugampillai Jeyarajaguru","family":"Kabilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganeshraja Ayyakannu","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alagarsamy Santhana Krishna","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.134406_bb0005","series-title":"Breast Cancer Metastasis and Drug Resistance: Progress and Prospects","first-page":"1","article-title":"Breast cancer statistics","author":"Ma","year":"2013"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0015","series-title":"Risk Factors of Breast Cancer in Rural & Urban India","author":"Nagrani","year":"2014"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0020","series-title":"Biologically Inspired Techniques in Many Criteria Decision Making: Proceedings of BITMDM 2021","first-page":"367","article-title":"A computational approach to assess breast cancer risk in relation with lifestyle factors","author":"Das","year":"2022"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.134406_bb0025","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00438-022-01914-1","article-title":"BRCA1, BRCA2, TP53, PIK3CA, PTEN and AKT1 genes mutations in Burkina Faso breast cancer patients: prevalence, spectrum and novel variant","volume":"297","author":"Ouedraogo","year":"2022","journal-title":"Mol. Gen. Genomics."},{"issue":"6009","key":"10.1016\/j.ijbiomac.2024.134406_bb0030","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1193494","article-title":"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes","volume":"330","author":"Levine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0035","series-title":"Breast Cancer Metastasis and Drug Resistance: Challenges and Progress","first-page":"1","article-title":"Breast cancer statistics: recent trends","author":"Ahmad","year":"2019"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/gutjnl-2011-300563","article-title":"Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer","author":"Andreyev","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0045","first-page":"17","article-title":"Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies","volume":"9","author":"Nounou","year":"2015","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biopha.2018.02.108","article-title":"Chemotherapeutic agents for the treatment of metastatic breast cancer: an update","volume":"101","author":"Abotaleb","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.134406_bb0055","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2174\/1389557516666160923125801","article-title":"Roles of pyridine and pyrimidine derivatives as privileged scaffolds in anticancer agents","volume":"17","author":"Prachayasittikul","year":"2017","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0060","series-title":"Metabolic Inhibitors","first-page":"239","article-title":"Pyrimidine analogues","volume":"vol. 1","author":"Brockman","year":"2012"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0065","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ijbiomac.2021.03.189","article-title":"Extraction of chlorophyll and carotenoids loaded into chitosan as potential targeted therapy and bio imaging agents for breast carcinoma","volume":"182","author":"Hanafy","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.134406_bb0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/FPC.0b013e32834a48a9","article-title":"Gene set analysis of purine and pyrimidine antimetabolites cancer therapies","volume":"21","author":"Fridley","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134406_bb0075","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/cells11040739","article-title":"Re-discovery of pyrimidine salvage as target in cancer therapy","volume":"11","author":"Walter","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3923\/ijp.2017.785.807","article-title":"Advantages of drug selective distribution in cancer treatment: brentuximab vedotin","volume":"13","author":"Luis Mario Villela-Martinez","year":"2017","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0085","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s40262-020-00934-7","article-title":"Intracellular pharmacokinetics of pyrimidine analogues used in oncology and the correlation with drug action","volume":"59","author":"Derissen","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0090","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/IJN.S289443","article-title":"Nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives","volume":"2021","author":"Edis","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.134406_bb0095","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/molecules23092157","article-title":"Enhancing the delivery of chemotherapeutics: role of biodegradable polymeric nanoparticles","volume":"23","author":"Ahlawat","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-chembioeng-060817-084055","article-title":"Biodegradable polymeric nanoparticles for therapeutic cancer treatments","volume":"9","author":"Karlsson","year":"2018","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110469","article-title":"A review: natural polysaccharides from medicinal plants and microorganisms and their anti-herpetic mechanism","volume":"129","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134406_bb0110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/polym14040813","article-title":"Current advances of polysaccharide-based nanogels and microgels in food and biomedical sciences","volume":"14","author":"Papagiannopoulos","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.mser.2023.100758","article-title":"Interaction chemistry of functional groups for natural biopolymer-based hydrogel design","volume":"156","author":"Hoque","year":"2023","journal-title":"Mater. Sci. Eng. R. Rep."},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.134406_bb0120","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1021\/la0348214","article-title":"Complex formation of whey proteins: exocellular polysaccharide EPS B40","volume":"19","author":"Weinbreck","year":"2003","journal-title":"Langmuir"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.646988","article-title":"Therapeutic and industrial applications of curdlan with overview on its recent patents","volume":"8","author":"Chaudhari","year":"2021","journal-title":"Front. Nutri."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0130","first-page":"1","article-title":"Fabrication, characterization and evaluation of gallic acid-encapsulated curdlan gum nanoparticles with potential application for breast cancer treatment","author":"Pandi","year":"2024","journal-title":"J. Polym. Environ."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111491","article-title":"Construction and characterization of folate-functionalized curdlan-trilysine siRNA delivery platform for in vivo hepatic carcinoma treatment","volume":"198","author":"Qi","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.134406_bb0140","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2174\/1871520619666190702145609","article-title":"Design, in silico modelling, and functionality theory of novel folate receptor targeted rutin encapsulated folic acid conjugated keratin nanoparticles for effective cancer treatment","volume":"19","author":"Kunjiappan","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129338","article-title":"Targeted therapies for breast and lung cancers by using Propolis loaded albumin protein nanoparticles","volume":"260","author":"Ghazy","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0150","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.ijbiomac.2021.05.149","article-title":"Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer","volume":"182","author":"Hanafy","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.134406_bb0155","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s00210-023-02480-y","article-title":"Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells","volume":"396","author":"Rajeshkumar","year":"2023","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134406_bb0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ddr.21758","article-title":"Surface receptor-mediated targeted drug delivery systems for enhanced cancer treatment: a state-of-the-art review","volume":"82","author":"Kunjiappan","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-380864-6.00004-3","article-title":"Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer","volume":"71","author":"Liu","year":"2010","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0170","first-page":"1","article-title":"Network pharmacology and experimental validation for deciphering the action mechanism of Fritillaria cirrhosa D. Don constituents in suppressing breast carcinoma","author":"Bhat","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2024.134406_bb0175","first-page":"D271","article-title":"The RCSB protein data bank: integrative view of protein, gene and 3D structural information","volume":"45","author":"Rose","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2008.03.017","article-title":"A perspective of publicly accessible\/open-access chemistry databases","volume":"13","author":"Williams","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0185","series-title":"Drug Designing in Discovery Studio","author":"Jejurikar","year":"2021"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0190","series-title":"Molecular Docking for Computer-Aided Drug Design","first-page":"463","article-title":"Docking-based virtual screening using PyRx Tool: autophagy target Vps34 as a case study","author":"Kondapuram","year":"2021"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.134406_bb0195","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab098","article-title":"Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein","volume":"22","author":"Ahammad","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"20","key":"10.1016\/j.ijbiomac.2024.134406_bb0200","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134406_bb0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1021\/acs.jced.3c00561","article-title":"Thermodynamics of water and ice from a fast and scalable first-principles neuroevolution potential","volume":"69","author":"Chen","year":"2023","journal-title":"J. Chem. Eng. Data"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134406_bb0210","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41598-021-83626-x","article-title":"Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein","volume":"11","author":"Opo","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.134406_bb0215","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1080\/07391102.2020.1773318","article-title":"Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor","volume":"39","author":"Veeramachaneni","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134406_bb0220","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ddr.21511","article-title":"Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2-(methyl\/phenyl)-3-(4-(5-substituted-1, 3, 4-oxadiazol-2-yl)-phenyl) quinazolin-4 (3H)-ones as NMDA receptor inhibitor","volume":"80","author":"Saravanan","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0225","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1007\/s10924-023-02848-4","article-title":"Drug delivery applications of exopolysaccharides from endophytic bacteria pseudomonas otitidis from Tribulus terrestris L","volume":"31","author":"Kalimuthu","year":"2023","journal-title":"J. Polym. Environ."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134406_bb0230","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.134406_bb0235","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab5c56","article-title":"Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment","volume":"31","author":"Kunjiappan","year":"2020","journal-title":"Nanotechnology"},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.134406_bb0240","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1002\/pola.23020","article-title":"Folate-mediated cell uptake of shell-crosslinked spheres and cylinders","volume":"46","author":"Zhang","year":"2008","journal-title":"J. Polym. Sci. Part A Polym. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0245","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1007\/s00216-016-9641-6","article-title":"Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles","volume":"408","author":"Souto","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.12659\/MSMBR.893327","article-title":"Dual AO\/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry","volume":"21","author":"Liu","year":"2015","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","article-title":"Mitochondrial membrane potential","volume":"552","author":"Zorova","year":"2018","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.134406_bb0260","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.trsl.2012.02.004","article-title":"Human umbilical cord blood mononuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia","volume":"159","author":"Henning","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-319-28549-8_6","article-title":"Integrated high-content quantification of intracellular ROS levels and mitochondrial morphofunction","volume":"219","author":"Sieprath","year":"2016","journal-title":"Adv. Anal. Embryol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0270","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s10924-023-03107-2","article-title":"Enhanced delivery of retinoic acid to breast cancer cells by folate receptor-targeted folic acid-conjugated glutenin nanoparticles for promising treatment of breast cancer","volume":"32","author":"Rajeshkumar","year":"2024","journal-title":"J. Polym. Environ."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134406_bb0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s43094-021-00274-8","article-title":"Pyrimidine: a review on anticancer activity with key emphasis on SAR","volume":"7","author":"Mahapatra","year":"2021","journal-title":"Future J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134406_bb0280","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1568026622666220111143949","article-title":"Pyrimidine-fused dinitrogenous penta-heterocycles as a privileged scaffold for anti-cancer drug discovery","volume":"22","author":"Li","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.134406_bb0285","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1021\/cr300410v","article-title":"Kinase inhibitors of marine origin","volume":"113","author":"Bharate","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105208","article-title":"New thieno [3, 2-d] pyrimidine-based derivatives: design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells","volume":"115","author":"Farghaly","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0295","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10924-021-02299-9","article-title":"Review on anti-cancer and anti-microbial applications of curdlan biomaterials","volume":"30","author":"Ganie","year":"2022","journal-title":"J. Polym. Environ."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134406_bb0300","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-3659(00)00256-X","article-title":"Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2)","volume":"69","author":"Na","year":"2000","journal-title":"J. Control. Release"},{"issue":"26","key":"10.1016\/j.ijbiomac.2024.134406_bb0305","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/21\/26\/265601","article-title":"Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin","volume":"21","author":"Li","year":"2010","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0310","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.carbpol.2014.09.069","article-title":"Preparation of novel curdlan nanoparticles for intracellular siRNA delivery","volume":"117","author":"Han","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.110096","article-title":"Review on the preparation, biological activities and applications of curdlan and its derivatives","volume":"141","author":"Chen","year":"2020","journal-title":"Eur. Polym. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134406_bb0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-409X(99)00062-9","article-title":"Targeted drug delivery via the folate receptor","volume":"41","author":"Sudimack","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134406_bb0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","article-title":"Nanoparticles for cancer therapy: current progress and challenges","volume":"16","author":"Gavas","year":"2021","journal-title":"Nanoscale Res. Lett."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.134406_bb0330","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems\u2014a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.134406_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051421","article-title":"Recent advances in the development of liquid crystalline nanoparticles as drug delivery systems","volume":"15","author":"Leu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jconrel.2014.06.038","article-title":"Insight into nanoparticle cellular uptake and intracellular targeting","volume":"190","author":"Yameen","year":"2014","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.134406_bb0345","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1021\/acs.accounts.8b00292","article-title":"Cellular uptake of nanoparticles versus small molecules: a matter of size","volume":"51","author":"Mosquera","year":"2018","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134406_bb0350","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1021\/cr300441a","article-title":"Uptake of engineered gold nanoparticles into mammalian cells","volume":"114","author":"Dykman","year":"2014","journal-title":"Chem. Rev."},{"issue":"27","key":"10.1016\/j.ijbiomac.2024.134406_bb0355","doi-asserted-by":"crossref","first-page":"16701","DOI":"10.1021\/acsomega.0c01582","article-title":"Zeta potential of extracellular vesicles: toward understanding the attributes that determine colloidal stability","volume":"5","author":"Midekessa","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-60327-198-1_6","article-title":"Zeta potential measurement, characterization of nanoparticles intended for drug delivery","volume":"697","author":"Clogston","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0365","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.msec.2016.09.016","article-title":"Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: a too simplistic explanation that does not take into account the nanoparticle protein corona","volume":"70","author":"Forest","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134406_bb0370","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jat.1385","article-title":"Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition","volume":"29","author":"Yang","year":"2009","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134406_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08674","article-title":"Drug release study of the chitosan-based nanoparticles","volume":"8","author":"Herdiana","year":"2022","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.134406_bb0380","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134406_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15087","article-title":"Facile construction of irinotecan loaded mesoporous nano-formulation with surface-initiated polymerization to improve stimuli-responsive drug delivery for breast cancer therapy","volume":"9","author":"Nie","year":"2023","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.134406_bb0390","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/biom9110735","article-title":"Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.134406_bb0395","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/ars.2020.8074","article-title":"Reactive oxygen species induced p53 activation: DNA damage, redox signalling or both?","volume":"33","author":"Shi","year":"2020","journal-title":"Antioxid. Redox Signal."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.134406_bb0400","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.onc.1209895","article-title":"A redox cycle within the cell cycle: ring in the old with the new","volume":"26","author":"Menon","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134406_bb0405","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/ph3040839","article-title":"Mitochondrial and cell death mechanisms in neurodegenerative diseases","volume":"3","author":"Martin","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134406_bb0410","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s10495-016-1333-3","article-title":"Methods to detect apoptotic cell death","volume":"22","author":"Banfalvi","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00418-007-0356-9","article-title":"Morphological and cytochemical determination of cell death by apoptosis","volume":"129","author":"Taatjes","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2024.134406_bb0420","series-title":"Master Degree Thesis at Faculty of Health Sciences, Department of Radiation Biology, Institute of Cancer Research, Oslo University Hospital and Oslo University College, Norway","article-title":"Synthetic lethality by inhibition of PARP in ATM-deficient lymphoid cells: reduced proliferation, replication induced DNA damage, G2 delay and cell death","author":"Rein","year":"2012"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024052115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024052115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T21:10:25Z","timestamp":1786396225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024052115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":84,"alternative-id":["S0141813024052115"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134406","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabrication of folic acid-conjugated pyrimidine-2(5H)-thione-encapsulated curdlan gum-PEGamine nanoparticles for folate receptor targeting breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134406"}}